Indication

Hyperlipoproteinemia (a)

1 clinical trial

1 product

Clinical trial

A Single Arm, Open Label Extension (OLE), Multicenter Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) in Patients With Cardiovascular Disease Who Have Successfully Completed the Apheresis Parent Study.

Status: Recruiting, Estimated PCD: 2028-08-24

Product